MLICM
MDRX

Metropolitan Life Insurance Company (MetLife)’s Veradigm Inc. Common Stock MDRX Stock Holding History

Metropolitan Life Insurance Company (MetLife)’s Portfolio MDRX Stock Details MDRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-6,499
Closed -$68.2K – 2363
2023
Q4 		$68.2K Hold
6,499
– – ﹤0.01% 1282
2023
Q3 		$85.4K Buy
6,499
+518
+9% +$6.79K ﹤0.01% 1095
2023
Q2 		$75.4K Hold
5,981
– – ﹤0.01% 1180
2023
Q1 		$78.1K Sell
5,981
-907
-13% -$14.7K ﹤0.01% 1135
2022
Q4 		$122K Hold
6,888
– – 0.01% 956
2022
Q3 		$105K Hold
6,888
– – 0.01% 986
2022
Q2 		$102K Sell
6,888
-1,016
-13% -$19K ﹤0.01% 1042
2022
Q1 		$178K Sell
7,904
-24,794
-76% -$502K 0.01% 876
2021
Q4 		$603K Sell
32,698
-1,226
-4% -$19.5K 0.01% 1298
2021
Q3 		$454K Sell
33,924
-4,770
-12% -$77K 0.01% 1530
2021
Q2 		$716K Sell
38,694
-7,761
-17% -$131K 0.01% 1265
2021
Q1 		$698K Sell
46,455
-1,296
-3% -$20.8K 0.01% 1201
2020
Q4 		$690K Hold
47,751
– – 0.01% 1152
2020
Q3 		$389K Sell
47,751
-6,390
-12% -$52.2K 0.01% 1380
2020
Q2 		$367K Sell
54,141
-32,386
-37% -$210K 0.01% 1428
2020
Q1 		$609K Sell
86,527
-7,407
-8% -$60.1K 0.01% 942
2019
Q4 		$922K Sell
93,934
-3,999
-4% -$42.1K 0.01% 940
2019
Q3 		$1.08M Sell
97,933
-1,075
-1% -$11K 0.02% 819
2019
Q2 		$1.15M Sell
99,008
-1,269
-1% -$12.9K 0.02% 817
2019
Q1 		$957K Sell
100,277
-899
-0.9% -$9.93K 0.02% 899
2018
Q4 		$975K Buy
101,176
+150
+0.1% +$1.67K 0.02% 824
2018
Q3 		$1.44M Sell
101,026
-5,305
-5% -$72.1K 0.02% 712
2018
Q2 		$1.28M Sell
106,331
-424
-0.4% -$5.22K 0.02% 799
2018
Q1 		$1.32M Buy
106,755
+2,182
+2% +$31K 0.02% 767
2017
Q4 		$1.52M Sell
104,573
-183,650
-64% -$2.55M 0.02% 690
2017
Q3 		$4.1M Sell
288,223
-1,349
-0.5% -$17.5K 0.03% 686
2017
Q2 		$3.69M Buy
289,572
+121,167
+72% +$1.47M 0.03% 726
2017
Q1 		$2.13M Sell
168,405
-4,579
-3% -$54.3K 0.01% 931
2016
Q4 		$1.77M Sell
172,984
-1,999
-1% -$22.8K 0.01% 1018
2016
Q3 		$2.31M Sell
174,983
-727
-0.4% -$9.72K 0.02% 905
2016
Q2 		$2.23M Buy
175,710
+1,778
+1% +$23.6K 0.02% 901
2016
Q1 		$2.3M Buy
173,932
+5,134
+3% +$67.4K 0.02% 852
2015
Q4 		$2.6M Buy
168,798
+879
+0.5% +$12.6K 0.02% 798
2015
Q3 		$2.08M Buy
167,919
+14,714
+10% +$203K 0.02% 896
2015
Q2 		$2.1M Buy
153,205
+619
+0.4% +$8.36K 0.01% 953
2015
Q1 		$1.82M Buy
152,586
+5,383
+4% +$65.8K 0.01% 921
2014
Q4 		$1.88M Buy
147,203
+1,453
+1% +$18.5K 0.01% 993
2014
Q3 		$1.96M Buy
145,750
+8,774
+6% +$133K 0.01% 957
2014
Q2 		$2.2M Buy
136,976
+3,367
+3% +$52.5K 0.02% 963
2014
Q1 		$2.41M Buy
133,609
+2,946
+2% +$51K 0.02% 891
2013
Q4 		$2.02M Buy
130,663
+804
+0.6% +$11.8K 0.01% 974
2013
Q3 		$1.93M Sell
129,859
-12,829
-9% -$193K 0.01% 953
2013
Q2 		$1.85M Buy
+142,688
New +$1.91M 0.01% 922

Other funds holding MDRX

SPC
Silver Point Capital Greenwich, Connecticut $1.3B AUM 18.3% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
TCM
Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return
OFCM
One Fin Capital Management San Francisco, California $280M AUM 49.87% 1-Year Est. Return
MCM
Mason Capital Management New York $613M AUM 21.43% 1-Year Est. Return
CM
Caption Management Oklahoma City, Oklahoma $17.1B AUM 70.99% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
PCMI
Paradigm Capital Management Inc Albany, New York $2.61B AUM 78.58% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Metropolitan Life Insurance Company (MetLife)'s MDRX Position: Q1 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 6,499 shares — an estimated $68.2K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in MDRX in Q2 2013 and held it in 43 quarters. The position peaked at $4.1M in Q3 2017. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 6,499 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $68.2K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in Veradigm Inc. Common Stock in Q2 2013 and held it in 43 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s Veradigm Inc. Common Stock position peaked at $4.1M in Q3 2017.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q1 2024, filed 14 May 2024.